These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6751336)

  • 21. Atrophic gastritis in Sjögren's syndrome. Morphologic, biochemical, and immunologic findings.
    Maury CP; Törnroth T; Teppo AM
    Arthritis Rheum; 1985 Apr; 28(4):388-94. PubMed ID: 3885959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methods for type I interferon detection and their relevance for clinical utility and improved understanding of rheumatic diseases.
    Lamot L; Niemietz I; Brown KL
    Clin Exp Rheumatol; 2019; 37(6):1077-1083. PubMed ID: 30943143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Raised C-reactive protein response in rheumatoid arthritis patients with secondary Sjögren's syndrome.
    Youinou P; Fauquert P; Pennec YL; Bendaoud B; Katsikis P; Le Goff P
    Rheumatol Int; 1990; 10(1):39-41. PubMed ID: 2353152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
    Ebo D; DeClerck LS; Bridts CH; Stevens WJ
    In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Characteristics of keratoconjunctivitis sicca in Sjögren's disease and syndrome].
    Safonova TN; Iudina IuV
    Ter Arkh; 1988; 60(4):30-1. PubMed ID: 3394092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble interleukin-2 receptors in serum from patients with primary Sjögren's syndrome.
    Diamant M; Tvede N; Prause JU; Oxholm P
    Scand J Rheumatol; 1991; 20(5):370-2. PubMed ID: 1947901
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum gastrin concentration in patients with rheumatoid arthritis associated or not with Sjögren's syndrome.
    Netter P; Faure G; Brassine A; Gaucher A; Franchimont P
    Biomed Pharmacother; 1982; 36(6-7):331-2. PubMed ID: 7183348
    [No Abstract]   [Full Text] [Related]  

  • 28. Sicca symptoms and secondary Sjögren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables.
    Gilboe IM; Kvien TK; Uhlig T; Husby G
    Ann Rheum Dis; 2001 Dec; 60(12):1103-9. PubMed ID: 11709451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjögren's syndrome.
    Szántó A; Csípo I; Zeher M
    J Rheumatol; 2005 Jan; 32(1):197; author reply 197-8. PubMed ID: 15630756
    [No Abstract]   [Full Text] [Related]  

  • 30. Decreased serum ACE2 levels in patients with connective tissue diseases.
    Tang X; Geng L; Feng X; Sun L
    Rheumatology (Oxford); 2021 Sep; 60(9):4401-4406. PubMed ID: 33369650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The complement system in necrotizing angiitis of the skin. Analysis of complement component activities in serum of patients with concomitant collagen-vascular diseases.
    Soter NA; Austen KF; Gigli I
    J Invest Dermatol; 1974 Aug; 63(2):219-26. PubMed ID: 4152325
    [No Abstract]   [Full Text] [Related]  

  • 32. [The value of salivary beta 2 microglobulin concentration for diagnosis of Sjögren's syndrome].
    Du D; Pu Y; Zhao Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Feb; 19(1):72-4. PubMed ID: 10453557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
    Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
    J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Previous diagnosis of Sjögren's Syndrome as rheumatoid arthritis or systemic lupus erythematosus.
    Rasmussen A; Radfar L; Lewis D; Grundahl K; Stone DU; Kaufman CE; Rhodus NL; Segal B; Wallace DJ; Weisman MH; Venuturupalli S; Kurien BT; Lessard CJ; Sivils KL; Scofield RH
    Rheumatology (Oxford); 2016 Jul; 55(7):1195-201. PubMed ID: 26998859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies to cellular antigens in Sjögren's syndrome.
    Alspaugh MA; Tan EM
    J Clin Invest; 1975 May; 55(5):1067-73. PubMed ID: 804494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inhibitory effect of sera from patients with rheumatic diseases on EA-rosette formation].
    Nasonov EL; Aleksandrova EN; Sura VV; Ivanova MM; Zimin IuI
    Ter Arkh; 1983; 55(7):32-7. PubMed ID: 6604958
    [No Abstract]   [Full Text] [Related]  

  • 37. Overview of Sjögren's syndrome.
    Talal N
    J Dent Res; 1987 Feb; 66 Spec No():672-4. PubMed ID: 3476632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elemental Analysis of Whole and Protein Separated Blood Serum of Patients with Systemic Lupus Erythematosus and Sjögren's Syndrome.
    Tóth CN; Baranyai E; Csípő I; Tarr T; Zeher M; Posta J; Fábián I
    Biol Trace Elem Res; 2017 Sep; 179(1):14-22. PubMed ID: 28124217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cryoglobulinemia in autoimmune rheumatic diseases. Evidence of circulating monoclonal cryoglobulins in patients with primary Sjögren's syndrome.
    Tzioufas AG; Manoussakis MN; Costello R; Silis M; Papadopoulos NM; Moutsopoulos HM
    Arthritis Rheum; 1986 Sep; 29(9):1098-104. PubMed ID: 3489468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased levels of circulating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjögren's syndrome.
    Bartoloni E; Ludovini V; Alunno A; Pistola L; Bistoni O; Crinò L; Gerli R
    Lupus; 2011 Aug; 20(9):928-35. PubMed ID: 21613330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.